“…In particular, 5‐HT1A agonists have been shown to produce antinociceptive effects in various visceral pain models in rodents (Abdel Salam & Baiuomy, 2007; Danzebrink & Gebhart, 1991; Galeotti et al, 1997; Korzeniewska‐Rybicka & Płaźnik, 2001; Rouzade et al, 1998; Sivarao et al, 2004). In line with these findings, we previously demonstrated that buspirone, a partial agonist of 5‐HT1A receptors, dose dependently inhibited visceromotor reactions and medullary neuronal responses to noxious colorectal distension in healthy awake dogs and anesthetized rats (Lyubashina et al, 2017; Panteleev et al, 2018, 2021). However, in other studies 5‐HT1A receptor activation led to pronociceptive effect (Coelho et al, 2001; Mickle et al, 2012), whereas 5‐HT1A antagonists attenuated visceral pain perception (Coelho et al, 1998; Lindström et al, 2009).…”